NASDAQ:CRNX

Crinetics Pharmaceuticals Stock Insider Trading

etoro logo Buy CRNX
*Your capital is at risk
$35.91
+0.530 (+1.50%)
At Close: Jun 23, 2026

Crinetics Pharmaceuticals Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -14.84. In total, the insiders bought 2.02M and sold 1.26M CRNX shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
-14.84
Buy 2.02M shares
Sell 1.26M shares
64% Buy Activity
Strong Negative Correlation
Sell Signal Medium Confidence
Apr 08, 2026

Analysis Breakdown:

  • Partially supported by a negative historical correlation.
  • Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date Type Person Role Amount
Jun 18, 2026
Buy
Stock Option (Right to Buy)
A-Award
Wierenga Wendell
Director
Director 9 730
Value: $349.0K
Jun 18, 2026
Buy
Common Stock
A-Award
Wierenga Wendell
Director
Director 5 925
Value: $212.5K
Jun 18, 2026
Buy
Stock Option (Right to Buy)
A-Award
Bedrosian Camille L
Director
Director 9 730
Value: $349.0K
Jun 18, 2026
Buy
Common Stock
A-Award
Bedrosian Camille L
Director
Director 5 925
Value: $212.5K
Jun 18, 2026
Buy
Stock Option (Right to Buy)
A-Award
Vivaldi Coelho Rogerio
Director
Director 9 730
Value: $349.0K
Jun 18, 2026
Buy
Common Stock
A-Award
Deardorf Caren
Director
Director 5 925
Value: $212.5K
Jun 18, 2026
Buy
Stock Option (Right to Buy)
A-Award
Deardorf Caren
Director
Director 9 730
Value: $349.0K
Jun 18, 2026
Buy
Common Stock
A-Award
Fust Matthew K
Director
Director 5 925
Value: $212.5K
Jun 18, 2026
Buy
Stock Option (Right to Buy)
A-Award
Fust Matthew K
Director
Director 9 730
Value: $349.0K
Jun 18, 2026
Buy
Common Stock
A-Award
Nichols Weston
Director
Director 5 925
Value: $212.5K
Jun 18, 2026
Buy
Stock Option (Right to Buy)
A-Award
Nichols Weston
Director
Director 9 730
Value: $349.0K
Jun 18, 2026
Buy
Common Stock
A-Award
Vivaldi Coelho Rogerio
Director
Director 5 925
Value: $212.5K
Jun 18, 2026
Buy
Common Stock
A-Award
Okey Stephanie
Director
Director 5 925
Value: $212.5K
Jun 18, 2026
Buy
Stock Option (Right to Buy)
A-Award
Okey Stephanie
Director
Director 9 730
Value: $349.0K
Jun 17, 2026
Sell
Common Stock
S-Sale
Okey Stephanie
Director
Director 6 292
Value: $224.1K
Jun 17, 2026
Sell
Common Stock
S-Sale
Okey Stephanie
Director
Director 608
Value: $22.0K
May 29, 2026
Sell
Common Stock
G-Gift
Struthers Richard Scott
President & CEO
CEO / President 222 200
Value: $0
May 29, 2026
Buy
Common Stock
G-Gift
Struthers Richard Scott
President & CEO
CEO / President 222 200
Value: $7.90M
May 29, 2026
Sell
Common Stock
G-Gift
Struthers Richard Scott
President & CEO
CEO / President 111 100
Value: $0
May 29, 2026
Sell
Common Stock
G-Gift
Struthers Richard Scott
President & CEO
CEO / President 222 200
Value: $0
May 29, 2026
Sell
Common Stock
G-Gift
Struthers Richard Scott
President & CEO
CEO / President 111 100
Value: $0
May 29, 2026
Buy
Common Stock
G-Gift
Struthers Richard Scott
President & CEO
CEO / President 222 200
Value: $7.90M
May 29, 2026
Sell
Common Stock
G-Gift
Struthers Richard Scott
President & CEO
CEO / President 80 000
Value: $0
May 29, 2026
Sell
Common Stock
G-Gift
Struthers Richard Scott
President & CEO
CEO / President 111 100
Value: $0
May 29, 2026
Buy
Common Stock
G-Gift
Struthers Richard Scott
President & CEO
CEO / President 111 100
Value: $3.95M

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT CRINETICS PHARMACEUTICALS INC
Crinetics Pharmaceuticals
Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist that has completed phase III clinical trial for the treatment of acromegaly, as well as completed phase II clinical trial to treat c...
GOLDEN STAR
Ticker Change Signal Date
IDYA
$28.98
20.46% Jun 12
DHI
$146.71
6.39% Jun 10
E
ETD
$20.67
4.79% Jun 05
EAT
$140.46
16.94% Jun 05
OSW
$24.00
17.08% Jun 04

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE